Search results
Nov 4, 2022 · The FDA has authorized new COVID-19 bivalent boosters for children as young as 5. The new COVID-19 boosters were authorized before being tested on humans, but experts say that they are still...
Sep 13, 2022 · No, if you want human clinical trial data specifically on the bivalent BA.4/5 booster, you’re gonna have to wait a little while. According to a company announcement on August 31, the human ...
Aug 30, 2022 · Because the Biden administration has pushed for a fall booster campaign to begin in September, the mRNA vaccine-makers Pfizer-BioNTech and Moderna have only had time to test the reformulated shots...
Feb 13, 2023 · In fact, even as newer variants—like BQ.1, BQ.1.1, and XBB.1.5—become dominant in the U.S., the bivalent boosters are continuing to protect against severe disease, hospitalization, and death. What’s the point of the booster if I can still get infected?
Feb 2, 2023 · Findings from this analysis of national pharmacy testing data show that a bivalent mRNA booster dose provided added protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2, 3, or 4 monovalent vaccine doses.
Jan 26, 2023 · The bivalent was also 61.8% effective against infection versus 24.9% for the monovalent vaccine. The study, which drew data from people 12 and over who were included in North Carolina’s vaccine registry, was done during a time when Omicron BQ.1 and BQ.1.1 were circulating.
Oct 3, 2022 · While the BQ and XBB variant families, which took hold in the U.S. in late 2022, are more immune-evasive than the original omicron strain, the bivalent booster still appears to be effective in reducing the risk of severe disease. If you’re eligible to receive the bivalent booster, get it.
